Genetically engineered mouse models of astrocytoma: GEMs in the rough?
- 30 June 2001
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 11 (3) , 177-190
- https://doi.org/10.1006/scbi.2000.0375
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutantOncogene, 2000
- Low penetrance genes associated with increased risk for breast cancerEuropean Journal Of Cancer, 2000
- Mutation ofPten/Mmac1in mice causes neoplasia in multiple organ systemsProceedings of the National Academy of Sciences, 1999
- High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in miceCurrent Biology, 1998
- Development and malignant progression of astrocytomas in GFAP-v-src transgenic miceOncogene, 1997
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- Cancer Cell CyclesScience, 1996
- Amplification and differential expression of members of theerbB-gene family in human glioblastomaJournal of Neuro-Oncology, 1994
- Effects of an Rb mutation in the mouseNature, 1992
- Long-Term Follow-up of von Recklinghausen NeurofibromatosisNew England Journal of Medicine, 1986